Jeito Capital
Jeito Capital is a leading global investment company focused on biopharmaceuticals. They finance and accelerate cutting-edge medical innovation with a patient benefit approach, supporting entrepreneurs through significant capital contributions and expert guidance.
Founded 2018 · Venture Capital
Paris (
France)
France)Investment Stages
Series A
Series B
Markets
Biopharmaceuticals
Oncology
Ophthalmology
Rare Skeletal Diseases
Severe Respiratory Diseases
Fibrosis
Immuno-oncology
Cardiovascular Disease
Immuno-Oncology Therapies
Auto-Immune Diseases
Neuromuscular Diseases
Cell Therapy
Gene Therapy
Portfolio Companies
Neogene Therapeutics, Sparing Vision, Pulmocide, Alentis Therapeutics, Quell Therapeutics, Advesya, NMD Pharma, EyeBio, Precirix, CDR-Life, HI-Bio, CatalYm, Noema Pharma, Corteria Pharmaceuticals
Related VC firms in France
Acequia Capital
Technology, Software, Data Analytics, Infrastructure, Manufacturing, Ai
Aglaé Ventures
Marketplaces, SaaS, Platform, Consumer Apps, DNVB, Fintech, Financial Services
Alpha Intelligence Capital
AI, Machine Learning, Robotics, Medical Technology, Cloud Computing, Enterprise Software, Automotive, Industrial Automation, Healthcare, Smart Homes, Smart Cities, Quantum Computing, Cybersecurity
Want more backlinks, traffic, and startup visibility?
Get your startup listed in 100+ directories automatically. Perfect for SaaS, AI, and tech startups.
Submit Your Startup